HIMS
xyz:
equity
· Hyperliquid
—
Equity perp — Hyperliquid synthetic derivative. For real-time exchange pricing, turn off the Crypto toggle and search the bare equity ticker.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Mark Price
$24.25
24h Change
+0.51%
Funding (8h)
-0.0135%
Open Interest
170,125
24h Volume
$1.38M
Oracle Price
$24.28
Mark − Oracle
-0.2381%
Prev Day Close
$24.12
As of (UTC)
2026-05-27 1:20:53
Daily candles — last 63 days
Funding rate history — last 7 days (8h cycles)
Positive funding = longs paying shorts (long-crowded). Negative = shorts paying longs (short-crowded).
Peers — same category
| Coin | Mark | 24h % |
|---|---|---|
| MU | $956.07 | +22.31% |
| SNDK | $1650.20 | +8.69% |
| NVDA | $214.24 | -1.44% |
| INTC | $123.55 | +2.17% |
| CRCL | $104.36 | -8.48% |
News headlines Yahoo Finance, 1h cache
-
Hims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofA
2026-05-26 18:54 · Yahoo
-
Live Longer and Better. Does ’Biohacking’ Really Work?
2026-05-26 13:24 · Yahoo
-
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock
2026-05-26 13:00 · Yahoo
-
How The Hims & Hers Health (HIMS) Story Is Shifting With GLP‑1 Hopes And Margin Questions
2026-05-24 08:09 · Yahoo
-
Hims & Hers Deepens Personalized Care Through Platform Expansion
2026-05-22 14:29 · Yahoo
-
HIMS Stock Extends 3-Day Rally: Hims & Hers Targets GLP-1 Gold Rush In Canada After Novo Nordisk Patent Expiry
2026-05-22 06:24 · Yahoo
-
The Silver Lining of Last Week's Hims & Hers Earnings Miss
2026-05-21 15:40 · Yahoo
-
Canadians can now get digital prescriptions for 'generic Ozempic'
2026-05-21 14:54 · Yahoo
-
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
2026-05-21 13:00 · Yahoo
-
Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada
2026-05-21 13:00 · Yahoo